FDA

The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

www.fda.gov

FDA RSS Channel

Display # 
Title Published Date
FDA targets unlawful internet sales of illegal prescription medicines during International Operation Pangea IX 10 June 2016
FDA approves first buprenorphine implant for treatment of opioid dependence 26 May 2016
FDA approves new treatment for inhalation anthrax 22 March 2016
FDA takes additional action to better understand safety of Essure, inform patients of potential risks 01 March 2016
FDA providing $2 million in new grants for natural history studies in rare diseases 29 February 2016
FDA seeks $5.1 billion total for FY 2017 10 February 2016
Califf, FDA top officials call for sweeping review of agency opioids policies 04 February 2016
FDA approves first drug to show survival benefit in liposarcoma 28 January 2016
FDA approves first drug to treat a rare enzyme disorder in pediatric and adult patients 08 December 2015
FDA approves Opdivo to treat advanced form of kidney cancer 24 November 2015
FDA approves new treatment for HIV 06 November 2015
FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa 19 October 2015
FDA approves new injectable drug to treat schizophrenia 09 October 2015
FDA approves Keytruda for advanced non-small cell lung cancer 05 October 2015
FDA approves first treatment for sexual desire disorder 19 August 2015
FDA takes action to protect consumers from potentially dangerous counterfeit medicines and devices sold online 03 July 2015
FDA approves anti-clotting drug Savaysa 15 January 2015
FDA warns consumers about fraudulent Ebola treatment products 14 August 2014
FDA issues guidance to support the responsible development of nanotechnology products 25 June 2014
FDA launches openFDA to provide easy access to valuable FDA public data 13 June 2014

Most Popular Now

Boehringer Ingelheim increases acce…

Boehringer Ingelheim is announcing an expansion of its Intellectual Property (IP) enforcement policy. The IP enforcement policy had already been amended in 2007 by an eas...

Read more

AstraZeneca licenses Zurampic to Gr…

AstraZeneca today announced that it has entered into a licensing agreement with Grünenthal GmbH for the exclusive rights to Zurampic (lesinurad) in Europe and Latin Ameri...

Read more

Pfizer presents promising data from…

Pfizer Inc. (NYSE:PFE) today announced encouraging new data from a Phase 1/2 study of lorlatinib, the proposed generic name for PF-06463922, Pfizer's investigational, nex...

Read more

Bayer Science & Education Found…

Applications for the Bayer Science & Education Foundation's international scholarship programs are now being accepted for this year's round. In the academic sector, ambit...

Read more

Merck announces survey results expl…

Merck, a leading science and technology company, today announced survey results of 250 global biopharmaceutical executives on how their companies will manage new risks as...

Read more

Merck Accelerator expands its reach…

Merck, a leading science and technology company, has started this week the application period for the next round of its Accelerator programs in Darmstadt, Germany, and Na...

Read more

Promising treatment prospects for i…

In Switzerland alone, more than 5,700 women are diagnosed with breast cancer each year, and almost 1,400 of those affected die of the disease. In many very invasive forms...

Read more

AstraZeneca enters commercialisatio…

AstraZeneca today announced it has entered into a commercialisation agreement with Aspen Global Incorporated (AGI), part of the Aspen Group, for rights to its global anae...

Read more

Boehringer Ingelheim and Harvard sc…

Boehringer Ingelheim today announced it has established a research collaboration with the Harvard Stem Cell Institute's - Harvard Fibrosis Network to discover new ways of...

Read more

Call for Abstracts: DIA EuroMeeting…

29 - 31 March 2017, Glasgow, UK. The DIA EuroMeeting 2017 provides a platform for experts from all relevant disciplines within the entire healthcare development and acce...

Read more

FDA targets unlawful internet sales…

The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, announced that it took action this week against 4,402 we...

Read more

New class of protein could treat ca…

A protein designed by researchers at Georgia State University can effectively target a cell surface receptor linked to a number of diseases, showing potential as a therap...

Read more

Digest World Pharma Newsletter

Subscribe to our weekly Digest World Pharma Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]